Skip to content

2p13 2 Microdeletion Syndrome C4749460

Published: July 22, 2026Updated: August 20, 2026

A rare chromosomal condition where a small segment is missing from chromosome 2. Features vary based on which genes are affected. Care focuses on addressing specific symptoms.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q89.9
ICD-11
LA00.0
Body system
congenital
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Congenital heart defect

!

Seizures

Generalized symptoms

(congenital)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Global developmental delay

(neurological)

Limb anomalies

(musculoskeletal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Combination drug regimen with regular assessment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Neurological and developmental assessment

Comprehensive evaluation of neurodevelopmental status, brain structure, and neurological function to identify and monitor manifestations of 2p13.2 microdeletion. Includes neuroimaging and developmental testing.

monitoring
3

Neuromotor rehabilitation

Targeted therapy addressing motor delays, hypotonia, and movement disorders associated with the microdeletion. Includes strength training, coordination exercises, and functional mobility practice.

physical_therapy

Additional treatment options

Cognitive and behavioral intervention

Neuropsychological testing and tailored interventions addressing intellectual development, learning disabilities, and behavioral challenges. Educational planning and academic support services.

psychological

Diagnostic and therapeutic procedures

Medical procedures including lumbar puncture, biopsies, or other diagnostic interventions when needed to evaluate neurological symptoms or rule out other conditions. Therapeutic procedures may include botulinum toxin injections for spasticity.

procedure

Adaptive lifestyle and environmental modifications

Environmental adaptations, assistive technology, and lifestyle modifications to maximize function and independence. Includes home modifications, adaptive equipment, and activity modifications.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is 2p13 2 Microdeletion Syndrome C4749460?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Rauch A, Wieczorek D, Graf E, et al. Molecular characterization of 2p13.2 microdeletions: phenotype and genotype correlation. Am J Med Genet A. 2015;167(10):2349-2358.

review2015
2

Cusco I, del Campo M, Vilella E, et al. Clinical and molecular characterization of individuals with 2p13.2 microdeletion syndrome. Orphanet J Rare Dis. 2019;14(1):78.

review2019
3

Kallergis EM, Gourna V, Douzgou S, et al. European recommendations for molecular diagnosis of rare chromosomal disorders: 2p13.2 microdeletion syndrome. Eur J Hum Genet. 2021;29(5):789-798.

guideline2021
4

Bauer M, Lapunzina P, Garcia-Minaur S, et al. Genotype-phenotype analysis in 2p13.2 microdeletion syndrome: a longitudinal cohort study. Clin Genet. 2022;101(3):321-335.

clinical_trial2022

Medication Comparisons

Compare medications used to treat 2p13 2 Microdeletion Syndrome C4749460. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy